Baclofen-induced catatonia: Modification by serotonergic agents

Neuropharmacology

Volumn 35, Issue 5, 1996, Pages 595-598

  Kasture, S B ^a   Mandhane, S N ^b   Chopde, C T ^b  

^a Department of Pharmacology   (India)

^b RTM NAGPUR UNIVERSITY   (India)

Author keywords

Baclofen; Catatonia; GABA(B) receptors; Serotonergic neurotransmission

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; BUSPIRONE; CYPROHEPTADINE; FENCLONINE; FENFLURAMINE; FLUOXETINE; PINDOLOL; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CATATONIA; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RATING SCALE; SEROTONINERGIC TRANSMISSION;

EID: 0030152065     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)84629-6     Document Type: Article

References (20)

1. B receptors to the same channels in hippocampus. Science. 234:1986;1261-1265.
2. Bowery N.G., Hill D.R., Hudson A.L., Doble A., Middlemiss D.N., Shaw J., Turnbull M.J. (-) Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature. 283:1980;92-94.
3. 1A autoreceptors in the raphe nuclei. Trends Pharmac. Sci. 7:1986;212-214.
4. Faigle J.W., Keberle H. The chemistry and kinetics of Lioresal. Postgrad. Med. J. 48((Supply 5)):1972;9-13.
5. Glaser T., Traber J. Buspirone: Action on serotonin receptors in calf hippocampus. Eur. J. Pharmac. 88:1983;137-138.
6. Gray J.A., Metz A., Goodwin G.M., Green A.R. The effect of the GABA mimetic drugs, progabide and baclofen, on the biochemistry and function of 5-hydroxy-tryptamine and noradrenaline. Neuropharmacology. 25:1986;711-716.
7. Gray J.A., Green A.R., Molyneux S.G. Effect of baclofen on the release of endogenous 5-HT from mouse cortex slices. Br. J. Pharmac. 87:1986;149p.
8. B sites in rat brain. Nature. 290:1981;149-152.
9. + conductance in guinea-pig hippocampal pyramidal cells maintained in vitro. Br. J. Pharmacol. 85:1985;833-841.
10. Kaarianen I. Effects of amino-oxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats. Acta Pharmacol. Toxicol. 39:1976;393-401.
11. Keller H.H., Schaffner R., Haefely W. Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Naunyn-Schmiedeb. Arch. Pharmacol. 294:1976;1-9.
12. Kulkarni S.K., Arzi A., Kaul P.N. Modification of drug-induced catatonia and tremors by quipazine in rats and mice. Jap. J. Pharmac. 30:1980;129-135.
13. Lucki I. Behavioral responses associated with serotonin receptors. Adv. Behav. Pharmac. 7:1990;119-148.
14. Mehta A.K., Ticku M.K. Baclofen induces catatonia in rats. Neuropharmacology. 26:1987;1419-1423.
15. Pycock C.J., Horton R.W., Marsden C.D. The behavioral effects of manipulating GABA function in the globus pallidus. Brain Res. 116:1976;353-359.
16. Pycock C.J., Horton R.W. Dopamine dependent hyperactivity in rat following manipulation of GABA-mechanism in the region of nucleus accumbens. J. Neural Transm. 45:1979;17-33.
17. Segal M. The action of serotonin in the rat hippocampal slice preparation. J. Physiol. 330:1980;423-440.
18. Siegel S. (1956) Nonparametric Statistics for the Behavioral Sciences (Harlow, H.F., Ed.), pp. 116-127. McGraw Hill Kogakusha, Tokyo.
19. VanderMaelen C.P., Wilderman R.C. Buspirone, a non-benzodiazepine anxiolytic drug, causes inhibition of serotonergic dorsal raphe neurons in the rat brain slice. Soc. Neurosci. 10:1984;259.
20. 1A receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6:1986;3474-3482.